Search

everythinglearnresearchcommunity

for

Search:↓

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Hair graying may be caused by stem cell depletion from stress or melanocyte damage.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

Regenerative medicine is effective and safe for treating vitiligo.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Removing REDD1 in mice increases skin fat by making fat cells larger and more numerous.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The serum effectively promotes hair growth and reduces gray hair without side effects.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

No cure exists for alopecia areata, and treatments are personalized.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Male hormones control a specific gene in hamster skin, with different hormones having varying effects.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

A two-step method was created in 2015 to make more cells that help with hair growth, but they need to be combined with other cells for 4 days to actually form new hair.